Pemetrexed and Erlotinib for Metastatic Colorectal Cancer

Clinical trial NCT02723578 · COMPLETED

Trial details

NCT number: NCT02723578
Sponsor: Yonsei University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2015-12-01
Primary completion: 2018-08-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.